Agenda item 7 Date 25/4/2013
|
|
- Christal Grant
- 5 years ago
- Views:
Transcription
1 MEDICINES OPTIMISATION STRATEGY to 25 APRIL 2013 BMIP Decision Discussion Information Follow up from last meeting Report author: Heather Gray Report signed off by: John Constable Purpose of the paper: To present the Medicines Optimisation Strategy for East and North Herts CCG Recommendations to the Board: To approve the East and North Herts CCG Medicines Optimisation Strategy Summary Medicines Optimisation Strategy Medicines are the most frequent health care intervention in the NHS accounting for over 11billion spend nationally. 8.8 billion of this prescribing is in primary care. East and North CCG expenditure on primary care prescribing was 71 million in 2012/13 About 14% of CCG budgets will pay for medicines The number of items prescribed by GPs is growing at around 5.3% annually In secondary care about 60% of medicines expenditure is on high cost drugs excluded from PbR. This expenditure is increasing by about 15% per year. CQC investigations into failing services continue to highlight poor medicines management of a contributory factor in some cases In 2007 over 86,000 medication errors were reported to the NPSA :100 of these caused death or severe harm Around 7% of all hospital admissions have been attributed to or associated with adverse drug reactions with up to two thirds of these being preventable. Up to 50% of patients do not take their prescribed medicines as intended. Inappropriate use of antibiotics is a significant problem and implicated in C. diff and MRSA infections. E&NHCCG Medicines Optimisation Strategy prepared by Pharmacy & Medicines Optimisation Team, Hertfordshire, Bedfordshire and Luton 1
2 The CCG is committed to ensuring an effective strategic oversight on the use of medicines so that this resource is used safely, efficiently and effectively to improve health and wellbeing of the population and will do this by. Engaging the public, patients and professionals in improving the quality, outcomes and value for patients from their use of medicines Establishing a culture of quality and safety assurance with respect to the use of medicines Managing the financial risk with respect to prescribing Ensuring there is specialist professional pharmaceutical support for commissioning medicines and pharmacy services To deliver these strategic goals we will need to achieve the following objectives: Objective 1: Effective Decision making We will identify all our partner organisations and stakeholders and establish effective networks in order to ensure that there is effective joint decision making to deliver innovative, quality and safe, prescribing and use of medicines across health care services. Objective 2 :Medicines safety We will ensure that there is high quality medicines governance and that mechanisms are in place to assure safe, effective and affordable medicines usage in healthcare services, reduce variation in prescribing and reduce medicines related healthcare acquired infections (C.diff and MRSA) and limit medicines related hospital admissions. Objective 3: Primary Care Prescribing The choice of medicines prescribed or recommended by practitioners in primary care will meet patients needs, be evidence based and cost-effective and efficient use of NHS resources. Objective 4: Effective commissioning for medicines optimisation We will commission providers who can show that medicines prescribed for patients accessing their services meet patients needs, are safe, evidence based and cost-effective and efficient use of NHS resources. Patients transferring between care settings will have appropriate advice and information about their medicines to enable on-going safe and effective use. Objective 5: Community Pharmacy We will engage with community pharmacists in Hertfordshire so that they are fully integrated with the CCG to maximise the opportunities in community pharmacy to achieve QIPP and medicines optimisation priorities Pharmacy & Medicines Optimisation Team E&NHCCG Medicines Optimisation Strategy prepared by Pharmacy & Medicines Optimisation Team, Hertfordshire, Bedfordshire and Luton 2
3 The Pharmacy and Medicines Optimisation team will support the delivery of the medicines optimisation strategy across the CCG. A medicines optimisation template report has been prepared for each practice and the current deployment of the team has been reviewed. The future deployment of the team will be agreed with CCG Medicines Management Prescribing lead and locality prescribing leads in order to best realise the CCG objectives. Conclusion The use of medicines presents significant financial, safety and reputational risk for East and North Herts CCG. This strategy offers an effective strategic oversight on the use of medicines so that this resource is used safely, efficiently and effectively to improve health and wellbeing of the people in East and North Herts CCG. Recommendation It is recommended that the Medicines Optimisation Strategy is approved by the Board. April 2013 Heather Gray John Constable E&NHCCG Medicines Optimisation Strategy prepared by Pharmacy & Medicines Optimisation Team, Hertfordshire, Bedfordshire and Luton 3
4 CCG Medicines Optimisation Strategy To improve the quality, outcomes and value for patients from their use of medicines Strategic Goals The CCG aims to ensure patients receive the most benefit from their medicines within the available resources and will do this by: Engaging the public, patients and professionals in improving the quality, outcomes and value for patients from their use of medicines Establishing a culture of quality and safety assurance with respect to the use of medicines Managing the financial risk with respect to prescribing Ensuring there is specialist professional pharmaceutical support for commissioning medicines and pharmacy services. 4
5 Context Medicines are the most frequent health care intervention in the NHS which if applied wisely can make a major impact to improve the health and wellbeing of a population. Modern medicines, however, are very potent and, increasingly, are designed to work at specific target sites in the body. This means that if a medicine is not used as intended it is unlikely to effective and may be harmful. Inappropriate use of medicines may also present significant financial, and reputational risk to CCGs. Medicines account for over 11billion spend nationally. 8.8 billion of this prescribing is in primary care. East and North CCG expenditure on primary care prescribing was 71 million in 2012/13 About 14% of CCG budgets will pay for medicines The number of items prescribed by GPs is growing at around 5.3% annually In secondary care about 60% of medicines expenditure is on high cost drugs excluded from PbR. This expenditure is increasing by about 15% per year. In 2008/9 over 520,000 bed days in England and Wales were attributed to adverse events caused by medicines. Costing the NHS over 235million. CQC investigations into failing services continue to highlight poor medicines management of a contributory factor in some cases In 2007 over 86,000 medication errors were reported to the NPSA :100 of these caused death or severe harm Around 7% of all hospital admissions have been attributed to or associated with adverse drug reactions with up to two thirds of these being preventable.. Up to 50% of patients do not take their prescribed medicines as intended. Inappropriate use of antibiotics is a significant problem and implicated in C. diff and MRSA infections. Medicines optimisation features in all the five domains NHS outcomes framework: Domains 1 Preventing people from dying prematurely 2 Enhancing the quality of life for patients with long term conditions 3 Helping people to recover from episodes of illhealth or following injury 4 Ensuring that people have a positive experience of care 5 Treating and caring for people in a safe environment; and protecting them from avoidable harm 5
6 Objectives The CCG is committed to ensuring an effective strategic oversight on the use of medicines so that this resource is used safely, efficiently and effectively to improve health and wellbeing of the population. To deliver these strategic goals we will need to achieve the following objectives: Objective 1: Effective Decision making We will identify all our partner organisations and stakeholders and establish effective networks in order to ensure that there is effective joint decision making to deliver innovative, quality and safe, prescribing and use of medicines across health care services. Objective 2 :Medicines safety We will ensure that there is high quality medicines governance and that mechanisms are in place to assure safe, effective and affordable medicines usage in healthcare services, reduce variation in prescribing and reduce medicines related healthcare acquired infections (C.diff and MRSA) and limit medicines related hospital admissions. Objective 3: Primary Care Prescribing The choice of medicines prescribed or recommended by practitioners in primary care will meet patients needs, be evidence based and cost-effective and efficient use of NHS resources. Objective 4: Effective commissioning for medicines optimisation We will commission providers who can show that medicines prescribed for patients accessing their services meet patients needs, are safe, evidence based and cost-effective and efficient use of NHS resources. Patients transferring between care settings will have appropriate advice and information about their medicines to enable on-going safe and effective use. Objective 5: Community Pharmacy We will engage with community pharmacists in Hertfordshire so that they are fully integrated with the CCG to maximise the opportunities in community pharmacy to achieve QIPP and medicines optimisation priorities 6
7 Objective 1: Effective Decision making We will identify all our partner organisations and stakeholders and establish effective networks in order to ensure that there is effective joint decision making to deliver innovative, quality and safe, prescribing and use of medicines across health care services. Action Appoint board level lead for medicines optimisation Ensure we have the resources to deliver the strategy and work closely with GP prescribing and clinical leads to realise its objectives Provide specialised medicines optimisation and therapeutic advice to the CCG Board, locality groups, GP practices and prescribers Maintain and develop the health economy decision making framework (the Hertfordshire Medicines Management Committee (HMMC) and the Primary Care Medicines Management group (PCMMG)) for introduction and use of medicines, meeting national criteria for good practice. Ensure engagement with local GP, nurses and practice staff through representation of locality groups on CCG prescribing strategy and planning groups Develop and communicate prescribing and medicines optimisation guidance from CCG decision making groups Ensure medicine optimisation is integrated in CCG clinical priority workstreams and integrate medicines optimisation expertise in the redesign of health services and patient pathways Establish links and joint working with council-based public health teams Improve/establish joint working and networking with relevant health care professionals, eg, Acute service, specialist pharmacists, specialist nurses, community specialists, community pharmacists, the Local Pharmaceutical Committee and the Local Medical Committee and the Local Professional Networks develop local workforce and education and training to support delivery of this strategy Commission services to ensure access to the required expertise to ensure safe, legal and effective use of medicines and develop systems to keep abreast of new medicines related guidance and legislation Be proactive in sharing best practice both within the organisation and externally 7
8 Develop a policy for working with the industry to promote innovation in line with national good practice guidance. Objective 2 :Medicines safety We will ensure that there is high quality medicines governance and that mechanisms are in place to assure safe, effective and affordable medicines usage in healthcare services, reduce variation in prescribing and reduce medicines related healthcare acquired infections (C.diff and MRSA) and limit medicines related hospital admissions. Actions Deliver improved prescribing systems for patients in accordance with national programmes Put in place effective systems to ensure safe and improved medicines optimisation across interfaces between all care settings (acute, mental health and community hospitals, intermediate care, care home, domiciliary. etc) Identify gaps and develop medicines optimisation services for the most vulnerable patients and patients at greatest risk of medicines related problems Improve assurance of medicines optimisation and safety and ensure medicines expertise by commissioning quality Medicines Information services Improve assurance of medicines management and safety by commissioning IT systems to inform decision making on prescribing and to provide intelligence about prescribing trends for GP practice Establish assurance processes for medicines governance Deliver a systematic assessment and shared learning process for medicines related events Consult and agree medicines safety audits of GP practices and ensure sign-up by all practices 8
9 Contribute to Local Authority and Hertfordshire and South Midlands Area Team and Local Professional Network quality improvement initiatives for community pharmacy services Liaise with the AT Accountable Officer (controlled drugs) to ensure safe and secure handling of controlled drugs within our CCG Deliver National Institute of Health and Care Excellence guidance/guidelines within national timeframes Deliver and local and national medicines related performance indicators Provide medicine governance information to GP practices. Ensure medicines safety through targeting medicines optimisation to high risk patients, including those on high risk medicines, polypharmacy or cared for in care homes or intermediate care Establish systems to confirm the communication of and implementation of HMMC and PCMMG decisions within the CCG Deliver improved patient safety, reduce medicines risk and avoidable hospital admissions by effective commissioning of services. Improve medicines optimisation and safety in care homes 9
10 Objective 3: Primary Care Prescribing The choice of medicines prescribed or recommended by practitioners in primary care will meet patients needs, be evidence based and cost-effective and efficient use of NHS resources. Actions Undertake annual horizon scanning for new drug developments Develop and disseminate evidence based prescribing guidelines to primary care practitioners Provide pharmaceutical and medicines optimisation support and expertise to all primary care prescribers and GP practices 10
11 Ensure the availability of up-to date and accurate prescribing data to provide intelligence to plan workstreams and to keep GP practices/primary care prescribers informed Use of effective software and computer assisted decision making technology Regular monitoring and feedback to practices on prescribing KPIs and costs Medicines optimisation arrangements to be addressed in all care pathway and pathway redesign including development of AQP services Increase the level of engagement between patients, pubic and health professionals to improve, quality outcomes and value for patients from their use of medicines. Improve the use of information for patients in relation to medicines and pharmacy services and engage the public through medicines waste reduction and self care campaigns. Identify and prioritise high risk patients with Long Term Conditions for regular clinical medication reviews Identify and prioritise high risk patients for referral to community pharmacy for New Medicines Service (NMS), or targeted Medicines Use Review (tmur) Objective 4: Effective commissioning for medicines optimisation We will commission providers who can show that medicines prescribed for patients accessing their services meet patients needs, are safe, evidence based and cost-effective and efficient use of NHS resources. Patients transferring between care settings will have appropriate advice and information about their medicines to enable on-going safe and effective use. Actions Ensure that there is joint decision making and working with neighbouring CCGs, acute and mental health trusts and community health services and other providers as appropriate to improves medicines optimisation 11
12 Contract specifications will set out our expectations for optimal use of medicines, these will include quality measures for prescribing and pharmacy services, and implementation of NICE guidance Maintain an effective, fair and transparent Individual Funding Request (IFR) process to ensure individual special circumstances can be considered objectively and fairly with respect to applications for funding medicines outwith current CCG policy Improve relationships to ensure best use of medicines across the interface between care settings (eg hospital to GP, hospital to care home) including Medicines Reconciliation on admission or transfer. Establish a protocol for referral of high risk patients to community pharmacists for New Medicines Service or targeted Medicines Use Review. Objective 5: Community Pharmacy We will engage with community pharmacists in Hertfordshire so that they are fully integrated with the CCG to maximise the opportunities in community pharmacy to achieve QIPP and medicines optimisation priorities Action Work collaboratively with community pharmacy contractors and the Hertfordshire and South Midlands Area Team in order to maximise community pharmacy engagement with the CCG and GP practices. Ensure all community pharmacy contractors are aware of CCG priorities and the potential to contribute to CCG and national QIPP and medicines optimisation priorities 12
13 Collaborate with the Hertfordshire and South Midlands Area Team and Hertfordshire Local Authority to develop community pharmacy workforce to meet national and local objectives Contribute to the Hertfordshire Pharmaceutical Need Assessment so that it reflects patients medicines management needs in each locality To collaborate with AT/Local Authority to benchmark community pharmacy services and support the Healthy Living Pharmacy accreditation scheme To use the pharmacy Local Professional Network for cross-sector pharmaceutical advice. Ref: Ensuring the delivery of prescribing, medicines management and pharmacy functions in primary and community care: an organisational competency framework and key functions checklist, October 2010 NPC The NHS Outcomes Framework 2013/14 13
CCG authorisation: the role of medicines management
May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets
More informationThis SLA covers an enhanced service for care homes for older people and not any other care category of home.
Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationDraft Commissioning Intentions
The future for Luton s primary care services Draft Commissioning Intentions 2013-14 The NHS will have less money to spend over the next three years. Overall, it has to make 20 billion of efficiency savings
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines
More informationTRUST BOARD TB(16) 44. Summary of Lord Carter recommendations Operational productivity and performance in English acute hospitals
TRUST BOARD TB(16) 44 Title: Action: Meeting: Summary of Lord Carter recommendations Operational productivity and performance in English acute hospitals FOR NOTING Date of meeting Purpose: The purpose
More informationIntroducing the NTDA. Medicines Optimisation and Pharmaceutical Services. Richard Seal Chief Pharmacist NHS Trust Development Authority
Introducing the NTDA Medicines Optimisation and Pharmaceutical Services Richard Seal Chief Pharmacist NHS Trust Development Authority What are the basic functions of the NHS TDA? Functions previously
More informationNorth Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8
North Central London Medicines Optimisation Network Medicines Optimisation Committee Terms of Reference North Central London Medicines Optimisation Network 1 of 8 Document control Date Version Amendments
More informationThe Value of Working in Partnership with Care Homes to Provide a Unique and Sustainable Approach to Malnutrition
The Value of Working in Partnership with Care Homes to Provide a Unique and Sustainable Approach to Malnutrition A presentation delivered by: Vittoria Romano, Registered Dietitian & Catherine Blanchard,
More information5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework?
Item Number: 6.3 Governing Body Meeting: 4 February 2016 Report Sponsor Anthony Fitzgerald Director of Strategy and Delivery Report Author Anthony Fitzgerald Director of Strategy and Delivery 1. Title
More informationHOSPITAL PHARMACY TRANSFORMATION PROJECT
HOSPITAL PHARMACY TRANSFORMATION PROJECT Andrew Davies, Professional Lead for Hospital Pharmacy, NHS Improvement @HospChiefPharm Aamer Safdar, Principal Pharmacist Lead for Education and Development, Guy
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationHow to use NICE guidance to commission high-quality services
How to use NICE guidance to commission high-quality services Acknowledgement We are grateful to the many organisations and individuals who have contributed to the development of this guide. A list of these
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationAre you ready to be liberated? Karen Middleton Chief Health Professions Officer
Are you ready to be liberated? Karen Middleton Chief Health Professions Officer Karen.middleton@dh.gsi.gov.uk Priorities for healthcare Patients at the centre of everything we do World class clinical outcomes
More informationThe Local Health Economy : Understanding Finance in the NHS
The Local Health Economy : Understanding Finance in the NHS Connaught Hall, Attleborough 20 May 2015 Ann Donkin, Accountable Officer Introduction to NHS Finance Complex to describe, both internally and
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationTitle of meeting: Primary Care Joint Commissioning Committee (JCC) Committees in Common (CIC). Date of Meeting 12 th April 2016 Paper Number 7
Title of meeting: Primary Care Joint Commissioning Committee (JCC) Committees in Common (CIC). Date of Meeting 12 th April 2016 Paper Number 7 Title Sponsoring Director (name and job title) Sponsoring
More informationClinical Pharmacists in General Practice March 2018
Clinical Pharmacists in General Practice March 2018 1. Background Following a successful national pilot programme, the General Practice Forward View committed over 100million to support an extra 1,500
More informationStrategy for Delivery of Clinical Quality and Patient Safety North Norfolk Clinical Commissioning Group.
Strategy for Delivery of Clinical Quality and Patient Safety North Norfolk Clinical Commissioning Group. 1. Introduction 1.1 The aim of this document is to set out the strategy for North Norfolk CCG (NNCCG)
More informationCare Home support and medicines optimisation: Community Pharmacy National Enhanced Service
Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem
More informationNHS Herts Valleys Clinical Commissioning Group Board Meeting 14 April 2016
NHS Herts Valleys Clinical Commissioning Group Board Meeting 14 April 2016 Title 2015/16 Annual Report and Accounts proposed approval process Agenda Item: 13 Purpose (tick one only) Decision or Approval
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Finance, Performance and Commissioning Committee Report 3. Key Messages: At the end of March 2017 the clinical commissioning
More information21 March NHS Providers ON THE DAY BRIEFING Page 1
21 March 2018 NHS Providers ON THE DAY BRIEFING Page 1 2016-17 (Revised) 2017-18 (Revised) 2018-19 2019-20 (Indicative budget) 2020-21 (Indicative budget) Total revenue budget ( m) 106,528 110,002 114,269
More informationJOB DESCRIPTION. Progressive: A learning organization, encouraging innovation and continuous improvement.
JOB DESCRIPTION Job Title: Medicines Management Support Assistant Pay Band: Band 3 Hours of Work: Responsible to: Accountable to: Base Point: Contract Type 37.5 hours per week Prescription Order Line Manager
More informationNorth School of Pharmacy and Medicines Optimisation Strategic Plan
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean christopher.cutts@hee.nhs.uk HEE North School of Pharmacy
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide
More informationSouth East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
More informationExecutive Summary points to consider by organisations providing Primary and Community Health services
pecialist Pharmacy ervice Medicines Use and afety A ummary of Pharmacy upport required to deliver Medicines Optimisation in Primary Care based and Community Health ervices: A guide for Organisational Boards
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference This Committee will report to NHS Halton CCG Governing Body on the development, improvement and monitoring of all areas of quality. This will include clinical effectiveness,
More informationTHE SERVICES. A. Service Specifications (B1) Ian Diley (Suffolk County Council)
THE SERVICES A. Service Specifications (B1) Service Specification No. Service Early Supported Discharge for Stroke Patients v5.0 Commissioner Lead Dr Mark Lim, T Woor (Suffolk Stroke Review Project Board)
More informationDRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service
DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service Executive summary: The Cornwall Sustainability and Transformation Plan known as Shaping our Future will describe a new model of
More information2015/16 Annual General Meeting
2015/16 Annual General Meeting Welcome Dr Hari Pathmanathan tweet #ENHCCGAGM follow us @enhertsccg Financially Healthy? 2015/16 Finance Report Alan Pond Chief Finance Officer Statutory financial duties
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationNICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
NICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes Louise Picton Medicines Advice Senior Adviser, Medicines and Prescribing Centre Outline
More informationDELIVERING THE LEFT SHIFT IN ACUTE ACTIVITY THE COMMUNITY MODEL
DELIVERING THE LEFT SHIFT IN ACUTE ACTIVITY THE COMMUNITY MODEL 1. Introduction The Strategic Outline Case (SOC) and subsequent developing Outline Business Case (OBC) for the reconfiguration of acute hospital
More informationDefining the Boundaries between NHS and Private Healthcare. MECCG Policy Reference: MECCG142
Defining the Boundaries between NHS and Private Healthcare MECCG Policy Reference: MECCG142 Target Audience Brief Description (max 50 words) Action Required Equality Impact Assessment Providers of private
More informationStrategic overview: NHS system
Strategic overview: NHS system Dr Keith Ridge, Chief Pharmaceutical Officer 1 November 2016 A collaborative approach Five Year Forward View Oct 2014 NHS planning guidance, Dec 2015: Every health and care
More informationGeneral Practice 5 Year Forward View Operational Plan Leicester, Leicestershire and Rutland (LLR) STP
Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group General Practice 5 Year Forward View Operational
More informationInitial education and training of pharmacy technicians: draft evidence framework
Initial education and training of pharmacy technicians: draft evidence framework October 2017 About this document This document should be read alongside the standards for the initial education and training
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationPublic health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36
Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationQuality and Leadership: Improving outcomes
Quality and Leadership: Improving outcomes Podiatry Managers/Allied Health Managers and Leaders 5 March 2014 Shelagh Morris OBE Acting Chief Allied Health Professions Officer 2 http://www.nhsemployers.org/aboutus/latest-news/pages/the-new-nhs-in-2013-infographic.aspx
More informationYour Care, Your Future
Your Care, Your Future Update report for partner Boards April 2016 Introduction The following paper has been prepared for the Board members of all Your Care, Your Future partner organisations: NHS Herts
More informationSCOTTISH BORDERS HEALTH & SOCIAL CARE INTEGRATED JOINT BOARD UPDATE ON THE DRAFT COMMISSIONING & IMPLEMENTATION PLAN
Appendix-2016-59 Borders NHS Board SCOTTISH BORDERS HEALTH & SOCIAL CARE INTEGRATED JOINT BOARD UPDATE ON THE DRAFT COMMISSIONING & IMPLEMENTATION PLAN Aim To bring to the Board s attention the Scottish
More informationRegional Medicines Optimisation Committees
Regional Medicines Optimisation Committees Operating Model First Edition, April 2017 NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans.
More informationMedicines Management Guidance
Medicines Management Guidance Status Final Version 1.0 Author Jon Boyd Version date 05/12/2016 Agreed by the following North West London CCGs: Central London West London Hammersmith and Fulham Hounslow
More informationPrimary Care Prescribing Cardiff and Vale University Health Board. Issued: December 2013 Document reference: 447A2013
Primary Care Prescribing Cardiff and Vale University Health Board Issued: December 2013 Document reference: 447A2013 Status of report This document has been prepared for the internal use of Cardiff and
More informationTitle: Replacement of the Commissioning Advisory Forum Agenda Item: 9
Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose
More informationVision 3. The Strategy 6. Contracts 12. Governance and Reporting 12. Conclusion 14. BCCG 2020 Strategy 15
Bedfordshire Clinical Commissioning Group Quality Strategy 2014-2016 Contents SECTION 1: Vision 3 1.1 Vision for Quality 3 1.2 What is Quality? 3 1.3 The NHS Outcomes Framework 3 1.4 Other National Drivers
More informationQUALITY STRATEGY
NHS Nene and NHS Corby Clinical Commissioning Groups QUALITY STRATEGY 2017-2021 Approved: By the Joint Quality Committee on 11 April 2017 Ratified: By the NHS Corby Clinical Commissioning Group on 25 April
More informationAnnex 3 Cluster Network Action Plan South Ceredigion and Teifi Valley Cluster Plan
Annex 3 Network Action Plan 06-7 South Ceredigion and Teifi Valley Plan The Network Development Domain supports GP Practices to work to collaborate to: Understand local needs and priorities. Develop an
More informationQuality Assurance Framework
Quality Assurance Framework NHS Bromley Clinical Commissioning Group Quality Assurance Framework was developed to support the commissioning, contract monitoring and procurement processes. NAME OF ORGANISATION/SERVICE
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT Date of Governing Body Meeting: Title of Report: Key Messages: Finance, Performance and Commissioning Committee Report At the end of September 2017 we have reported an inyear deficit
More informationWolverhampton Clinical Commissioning Group - Care Home Document
Wolverhampton Clinical Commissioning Group - Care Home Document 1 Contents Page 1. Purpose 2. Workstreams Completed 3. 2014/15 Workstreams 4. Future Workstreams 2 1. Purpose 1.1. Introduction 1.1.1. This
More informationGuideline scope Intermediate care - including reablement
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Intermediate care - including reablement Topic The Department of Health in England has asked NICE to produce a guideline on intermediate
More informationBirmingham Solihull and the Black Country Area Team
Birmingham Solihull and the Black Country Area Team A summary of the Five Year Primary Care Strategy: High quality care for all now and for future generations 1 NHS England The Birmingham, Solihull and
More informationThe PCT Guide to Applying the 10 High Impact Changes
The PCT Guide to Applying the 10 High Impact Changes This Guide has been produced by the NHS Modernisation Agency. For further information on the Agency or the 10 High Impact Changes please visit www.modern.nhs.uk
More informationHerts Urgent Care. Cambridgeshire & Peterborough Integrated Urgent Care Service. David Archer Chief Executive. 14 th September 2016
Herts Urgent Care Cambridgeshire & Peterborough Integrated Urgent Care Service David Archer Chief Executive 14 th September 2016 History 2007 - Herts Urgent Care formed from the merger of two smaller GP
More informationReviewing and Assessing Service Redesign and/or Change Proposals
Reviewing and Assessing Service Redesign and/or Change Proposals RCN guidance CLINICAL PROFESSIONAL RESOURCE Acknowledgements Helen Donovan, RCN Professional Lead for Public Health Nursing David Dipple,
More informationAintree University Hospital NHS Foundation Trust Corporate Strategy
Aintree University Hospital NHS Foundation Trust Corporate Strategy 2015 2020 Aintree University Hospital NHS Foundation Trust 1 SECTION ONE: BACKGROUND AND CONTEXT 1 Introduction Aintree University Hospital
More informationMedicines optimisation in care homes
Medicines optimisation in care homes Programme overview March 2018 NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops.
More informationA new integrated model for Care Homes from Walsall CCG/Healthcare NHS Trust
A new integrated model for Care Homes from Walsall CCG/Healthcare NHS Trust Sally Roberts - Director of Governance, Quality & Safety. Walsall CCG Katie Welborn Advanced Nurse Practitioner- Walsall Healthcare
More informationDriving and Supporting Improvement in Primary Care
Driving and Supporting Improvement in Primary Care 2016 2020 www.healthcareimprovementscotland.org Healthcare Improvement Scotland 2016 First published December 2016 The publication is copyright to Healthcare
More informationCluster Network Action Plan Neath Cluster. Abertawe Bro Morgannwg University Health Board Neath Cluster Action Plan
Cluster Network Action Plan 2016-17 Neath Cluster 1 Introduction The Neath Cluster Network includes a cluster of 8 GP practices, seven of the practices are engaged in GP training. The cluster network estate
More informationIs Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better?
Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Vanessa Burgess, Assistant Director, Medicines & LTCs, NHS Lambeth Clinical Commissioning Group;
More informationCommunity Pharmacy in 2016/17 and beyond
Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,
More informationNHS Trafford Clinical Commissioning Group Quality and Performance Strategy S T rafford Clinical Commissioning Group
De ce m be r 20 14 NHS Trafford Clinical Commissioning Group Quality and Performance Strategy N H 2015-2020 S T rafford Clinical Commissioning Group Version 2.0 Page 1 of 28 APRIL 2015 (RM) POLICY DOCUMENT
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. Service E08/S/b Neonatal Intensive Care Transport Commissioner Lead Provider Lead Period Date of Review 12 Months 1. Population
More informationCouncil of Members. 20 January 2016
Council of Members 20 January 2016 Feedback on election process: Council of Members Chair and Deputy Chair Malcolm Hines, Chief Financial Officer Minutes of last meeting: 14 October 2015 Dr. Richard Proctor,
More informationBristol CCG North Somerset CGG South Gloucestershire CCG. Draft Commissioning Intentions for 2017/2018 and 2018/2019
Bristol CCG North Somerset CGG South Gloucestershire CCG Draft Commissioning Intentions for 2017/2018 and 2018/2019 Programme Area Key intention Primary and community care Sustainable primary care Implement
More informationLincolnshire JSNA: Chronic Obstructive Pulmonary Disease (COPD)
Disease (COPD) What do we know? Summary is a long-term condition, which is affecting increasing numbers of people. There is a wide range of interventions to address COPD, from prevention to the ongoing
More informationThe Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales.
Welsh Affairs Committee. Purpose: The Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales. Contact: Nesta Lloyd Jones, Policy and Public Affairs
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationNHS Bradford Districts CCG Commissioning Intentions 2016/17
NHS Bradford Districts CCG Commissioning Intentions 2016/17 Introduction This document sets out the high level commissioning intentions of NHS Bradford Districts Clinical Commissioning Group (BDCCG) for
More informationImproving Patient Outcomes Strategy
Improving Patient Outcomes Strategy 2015-2018 Hertford County I Lister I Mount Vernon Cancer Centre I QEII Improving Patient Outcomes Strategy 2015-2018 Page 1. Executive Summary 1 2. Introduction 2 3.
More informationMEMORANDUM OF UNDERSTANDING THE PROVISION OF PUBLIC HEALTH ADVICE TO NHS COMMISSIONING IN ROTHERHAM
MEMORANDUM OF UNDERSTANDING THE PROVISION OF PUBLIC HEALTH ADVICE TO NHS COMMISSIONING IN ROTHERHAM 1. Parties to the agreement: Rotherham Metropolitan Borough Council ( the Council ) NHS Rotherham Clinical
More informationDeveloping primary care in Barnet
Developing primary care in Barnet Introduction In January 2012, the Joint Boards of NHS North Central London (NCL) approved a NCL Primary Care Strategy, which describes development of the primary care
More informationNorthumberland, Tyne and Wear NHS Foundation Trust. Board of Directors Meeting. Meeting Date: 25 October Executive Lead: Rajesh Nadkarni
Agenda item 9 ii) Northumberland, Tyne and Wear NHS Foundation Trust Board of Directors Meeting Meeting Date: 25 October 2017 Title and Author of Paper: Clinical Effectiveness (CE) Strategy update Simon
More informationJOB DESCRIPTION. Deputy Director of Nursing - Tissue Viability. Director of Nursing. Tissue Viability Support Tissue Viability Nurse
JOB DESCRIPTION Job Title: Reporting to (title): Tissue Viability Nurse Specialist Deputy Director of Nursing - Tissue Viability Professionally Accountable to (title): Responsible for Supervising (if appropriate):
More informationHospital Pharmacy Transformation Plan
Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &
More informationSouth Powys Cluster Plan
South Powys Cluster Plan 2016-17 The Cluster Network Development Domain with the Quality & Outcomes Framework supports medical practices to work collaboratively to: Understand local health needs and priorities
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4. Mandatory but detail for local determination and agreement Optional headings 5-7. Optional to use, detail for local determination
More informationReport to Governing Body 19 September 2018
Report to Governing Body 19 September 2018 Report Title Author(s) Governing Body/Clinical Lead(s) Management Lead(s) CCG Programme Purpose of Report Summary NHS Lambeth Clinical Commissioning Group (CCG)
More informationMedicines Governance Service to Care Homes (Care Home Service)
Medicines Governance Service to Care Homes (Care Home Service) Locally Enhanced Service Authors: Ruth Buchan, Senior Pharmacist Medicines Management 4th Floor F Mill Dean Clough Halifax HX3 5AX Tel-01422
More informationCODE OF CONDUCT WHERE GP PRACTICES OR CONSORTIA ARE POTENTIAL PROVIDERS OF CCG COMMISISONED SERVICES
CODE OF CONDUCT WHERE GP PRACTICES OR CONSORTIA ARE POTENTIAL 1. Introduction PROVIDERS OF CCG COMMISISONED SERVICES 1.1. Managing potential conflicts of interest appropriately is needed to protect the
More informationGP Cover of Nursing, Residential, Extra Care and Intermediate Care Homes. Camden Clinical Commissioning Group. Care Home LES Spec v1
Local Enhanced Service Clinical Lead Commissioner Reporting Mechanism/Frequency Payment Frequency Payment Contact This Version GP Cover of Nursing, Residential, Extra Care and Intermediate Care Homes Dr
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationStandards for the initial education and training of pharmacy technicians. October 2017
Standards for the initial education and training of pharmacy technicians October 2017 The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium,
More informationQuality Accounts: Corroborative Statements from Commissioning Groups. Nottingham NHS Treatment Centre - Corroborative Statement
Quality Accounts: Corroborative Statements from Commissioning Groups Quality Accounts are annual reports to the public from providers of NHS healthcare about the quality of services they deliver. The primary
More informationWOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014
WOLVERHAMPTON CCG Governing Body Meeting ` Agenda item:12 TITLE OF REPORT: REPORT PRESENTED BY: Commissioning Committee Summary Dr Kamran Ahmed Title of Report: Update from the Commissioning Committee
More informationQuality Strategy. CCG Executive, Quality Safety and Risk Committee Approved by Date Issued July Head of Clinical Quality & Patient Safety
Quality Strategy Document Document Status Equality Impact Assessment Draft None Document Ratified/ CCG Executive, Quality Safety and Risk Committee Approved by Date Issued July 2016 Review Date September
More informationNHS operational productivity: unwarranted variations Mental health services Community health services Lord Carter 24 May 2018
NHS operational productivity: unwarranted variations Mental health services Community health services Lord Carter 24 May 2018 Ann Jacklin Professional Pharmacy Advisor Mental health & Community services
More informationNew Care Models Pharmacy Services in Care Homes. Pauline Walton
New Care Models Pharmacy Services in Care Homes Pauline Walton East & North Hertfordshire Background By 2030 the number of older people with care needs is predicted to rise by 61% 2,000 extra carers needed
More informationUtilisation Management
Utilisation Management The Utilisation Management team has developed a reputation over a number of years as an authentic and clinically credible support team assisting providers and commissioners in generating
More informationGeneric Job Description Consultant Pharmacist. Job Purpose
Generic Job Description Consultant Pharmacist Grade: Based at: 8b-d Operating sites as required Accountable to: Head of Pharmacy/Clinical Director of Pharmacy/ Divisional director or equivalent Managed
More information